Lumiera Health Inc.
NHPH.V
TSX
| 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | 08/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 8.41% | -29.55% | -184.60% | -123.59% | 1.25% |
| Total Depreciation and Amortization | -65.76% | -45.66% | -24.71% | -2.82% | 30.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 419.80% | 225.27% | 156.59% | 202.12% | -391.63% |
| Change in Net Operating Assets | 171.00% | 2,798.68% | 374.85% | 180.26% | 127.65% |
| Cash from Operations | 81.89% | 71.20% | 61.29% | 52.00% | 8.47% |
| Capital Expenditure | 100.00% | -- | -- | -30.77% | 73.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | -100.68% | -100.68% | -100.68% | -78.94% |
| Total Debt Issued | -68.75% | 15.53% | 163.23% | 4,615.00% | 4,615.00% |
| Total Debt Repaid | 99.65% | 99.20% | 99.45% | 36.50% | 38.71% |
| Issuance of Common Stock | -- | -- | -- | -- | -77.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -18.88% |
| Cash from Financing | -67.76% | -62.55% | -27.37% | -53.06% | -27.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 91.07% | 90.62% | 82.95% | 36.49% | -209.59% |
